PMDA Stepping Up Generic Compliance Inspections from August Approvals

April 16, 2024
Junko Sato (right), Associate Executive Director for Non-Clinical and Clinical Compliance, PMDA, and Kazunori Takagi, Director, Office of Generic Drugs, PMDA The Pharmaceuticals and Medical Devices Agency (PMDA) is enhancing the compliance inspections of generic drugs beginning with products that...read more